Stem Cell Treatment for Dry Eye Disease
Part of Eyes & vision clinical trials.
This early-stage trial tests whether special cells derived from umbilical cord tissue can help treat dry eye disease. The treatment uses tiny particles called extracellular vesicles that may reduce eye dryness and improve comfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have dry eye disease in both eyes with symptoms like dryness, burning, or eye fatigue
- Your eyes must have specific test results showing tear film problems and a dry eye symptom score of 13 or higher
- You must be able to see at least 0.1 on the vision chart with correction in both eyes
- You cannot have had eye infections, eye surgery, or certain eye treatments in the past 30 days or longer
- You cannot be pregnant, nursing, or unwilling to use contraception during the study
- You must have stable control of other health conditions like high blood pressure or diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental eye drop made from human platelets (blood cells that help healing) for people with moderate to severe dry eye. The drop is compared to a placebo (fake drop) to see if it improves eye comfort and surface health.
This trial tests a new eye drop made from stem cells to see if it can help relieve dry eye symptoms. It is for people with moderate to severe dry eye who haven't had recent eye surgery or used other eye drops.
This trial tests whether stem cell fortified eye drops can improve tear film stability, tear volume, and dry eye symptoms. If you have dry eye disease and haven't had eye surgery or certain other eye conditions, you may be able to join.
This trial tests whether stem cell injections into the eye can help people with severe dry eye caused by graft-versus-host disease that hasn't gotten better with standard treatments. It aims to reduce eye pain and improve vision.
This trial tests an eye drop solution for people with chronic dry eye caused by graft-versus-host disease after a stem cell transplant. It aims to see if the drops can reduce eye discomfort and improve the eye surface.
This study tests whether a special substance from stem cells (called secretome) can help heal chronic surface problems on the eye that haven't gotten better with standard treatments. It's for people with a stubborn scratch or defect on the cornea that has lasted more than 14 days.
Hear when a new Dry Eye Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.